Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
ZimVie Inc.Listing unverified | Sell | $9.3M | SEC | ||
AMAG PHARMACEUTICALS, INC.Listing unverified | Sell | $59.6M | SEC | ||
AMAG PHARMACEUTICALS, INC.Listing unverified | Buy | $237.8K | conv 25Cluster | SEC | |
AMAG PHARMACEUTICALS, INC.Listing unverified | Buy | $31.2K | conv 24Cluster | SEC | |
AMAG PHARMACEUTICALS, INC.Listing unverified | Buy | $387K | conv 37ClusterFirst in 12mo | SEC | |
AMAG PHARMACEUTICALS, INC.Listing unverified | Buy | $2.3M | conv 56ClusterFirst in 12mo | SEC | |
AMAG PHARMACEUTICALS, INC.Listing unverified | Buy | $30.3K | conv 37ClusterFirst in 12mo | SEC | |
Protalix BioTherapeutics, Inc.Listing on record | Sell | $800K | SEC | ||
CSI MINNESOTA, INC.Listing unverified | Sell | $1.3M | SEC | ||
CSI MINNESOTA, INC.Listing unverified | Sell | $24.2M | SEC | ||
CSI MINNESOTA, INC.Listing unverified | Buy | $1.9M | conv 29 | SEC | |
SEQUENOM INCListing unverified | Buy | $310.1K | conv 8 | SEC | |
SEQUENOM INCListing unverified | Buy | $119.3K | conv 7 | SEC | |
SEQUENOM INCListing unverified | Buy | $648.5K | conv 10 | SEC | |
SEQUENOM INCListing unverified | Buy | $28.2K | conv 7 | SEC | |
SEQUENOM INCListing unverified | Buy | $556.4K | conv 8 | SEC | |
SEQUENOM INCListing unverified | Buy | $25.2K | conv 7 | SEC | |
SEQUENOM INCListing unverified | Buy | $25.2K | conv 7 | SEC | |
SEQUENOM INCListing unverified | Buy | $556.4K | conv 8 | SEC | |
SEQUENOM INCListing unverified | Buy | $28.2K | conv 7 | SEC | |
SEQUENOM INCListing unverified | Buy | $281.2K | conv 8 | SEC | |
SEQUENOM INCListing unverified | Buy | $403K | conv 10 | SEC | |
SEQUENOM INCListing unverified | Buy | $344.8K | conv 8 | SEC | |
Protalix BioTherapeutics, Inc.Listing on record | Buy | $435.7 | conv 20 | SEC | |
Protalix BioTherapeutics, Inc.Listing on record | Buy | $4M | conv 60Unusual size | SEC |